Tel: 1-631-504-6093
Email:
Awesome Features1111

Slide Title 2

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas pulvinar nibh purus, eget convallis erat efficitur eget.

Read More

Awesome Features1111

This is description for slide three1111

Read More

p53 target new drug! Aprea’s Blood Cancer Combination Therapy Receives FDA Breakthrough Therapy Designation

Aprea Therapeutics is a Boston-based biopharmaceutical company focused on developing and commercializing innovative cancer therapies that reactivate the tumor suppressor protein p53. Recently, the company announced that the U.S. food […]

Read More →

Science Translational Medicine: Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes p53-deficient cancers to mTOR inhibition

In a new study, using advances in nanotechnology, researchers have found that restoring p53 not only delays the growth of p53-deficient liver and lung cancer cells, but may also make cancer drugs mTOR inhibitors […]

Read More →